These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 1501114)

  • 1. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
    Edwards RM; Aiyar N; Ohlstein EH; Weidley EF; Griffin E; Ezekiel M; Keenan RM; Ruffolo RR; Weinstock J
    J Pharmacol Exp Ther; 1992 Jan; 260(1):175-81. PubMed ID: 1309870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
    Cody RJ; Binkley PF; Haas GJ; Brown DM
    Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
    Wang YX; Gavras I; Wierzba T; Gavras H
    J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
    Cassis LA; Rippetoe PE; Soltis EE; Painter DJ; Fitz R; Gillespie MN
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
    Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
    Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
    J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018.
    Kushida H; Nomura S; Morita O; Harasawa Y; Suzuki M; Nakano M; Ozawa K; Kunihara M
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1042-53. PubMed ID: 7562467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogs.
    Brooks DP; Fredrickson TA; Weinstock J; Ruffolo RR; Edwards RM; Gellai M
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):673-8. PubMed ID: 1635591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.